2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Preparation of a novel lipid-core micelle using a low-energy emulsification method.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          High-energy methods for the manufacturing of nanomedicines are widely used; however, interest in low-energy methods is increasing due to their simplicity, better control over the process, and energy-saving characteristics during upscaling. Here, we developed a novel lipid-core micelle (LCM) as a nanocarrier to encapsulate a poorly water-soluble drug, nifedipine (NFD), by hot-melt emulsification, a low-energy method. LCMs are self-assembling colloidal particles composed of a hydrophobic core and a hydrophilic shell. Hybrid materials, such as Gelucire 44/14, are thus excellent candidates for their preparation. We characterized the obtained nanocarriers for their colloidal properties, drug loading and encapsulation efficiency, liquid state, stability, and drug release. The low-energy method hot-melt emulsification was successfully adapted for the manufacturing of small and narrowly dispersed LCMs. The obtained LCMs had a small average size of ~ 11 nm and a narrow polydispersity index (PDI) of 0.228. These nanocarriers were able to increase the amount of NFD dispersible in water more than 700-fold. Due to their sustained drug release profile and the PEGylation of Gelucire 44/14, these nanocarriers represent an excellent starting point for the development of drug delivery systems designed for long circulation times and passive targeting.

          Related collections

          Author and article information

          Journal
          Drug Deliv Transl Res
          Drug delivery and translational research
          Springer Science and Business Media LLC
          2190-3948
          2190-393X
          December 2018
          : 8
          : 6
          Affiliations
          [1 ] Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santos Dumont 964, 4to piso, Of. 09, Independencia, 8380494, Santiago, Chile.
          [2 ] Advanced Center for Chronic Diseases (ACCDiS), 8380494, Santiago, Chile.
          [3 ] Pharmaceutical and Biomaterial Research Group, Department of Health Sciences, Luleå University of Technology, 97187, Luleå, Sweden.
          [4 ] Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santos Dumont 964, 4to piso, Of. 09, Independencia, 8380494, Santiago, Chile. jomorales@ciq.uchile.cl.
          [5 ] Advanced Center for Chronic Diseases (ACCDiS), 8380494, Santiago, Chile. jomorales@ciq.uchile.cl.
          [6 ] Pharmaceutical and Biomaterial Research Group, Department of Health Sciences, Luleå University of Technology, 97187, Luleå, Sweden. jomorales@ciq.uchile.cl.
          Article
          10.1007/s13346-018-0521-9
          10.1007/s13346-018-0521-9
          29663150
          7d83355d-bbd3-4785-a659-e05fa88f8149
          History

          Hot-melt emulsification,Lipid-core micelles,Low-energy method,Nanocarriers,Poorly water soluble drugs

          Comments

          Comment on this article